Results of a rodent model show that fibrin-specific core-shell nanogels with a tissue-type plasminogen activator warrants more study as a treatment for patients with DIC.
Whether inherited or acquired, bleeding disorders can cause significant pain, inconvenience, and stress in a person’s life. When patients think they or a loved one may have a bleeding disorder, what should they know?
A group of US-based hemophilia experts summarized unmet needs in mild to moderate hemophilia and provided suggestions for healthcare professionals to optimally manage their patients with this challenging condition.
Pediatric patients with hemophilia may have impairments in postural balance, which could be an early sign of musculoskeletal disorders, and its assessment should be included in evaluations.
Among patients with severe hemophilia A, lower levels of platelet surface phosphatidylserine were found to be linked with bleeding risk.
These guidelines from ASH, ISTH, NHF, and WFH are intended to support patients, clinicians, and healthcare professionals in their decisions affecting the management of VWD.
This study aimed to investigate the effects of manual therapy combined with home exercises for young adult patients with hemophilic arthropathy of the lower limb joints.
Treatment options for Hemophilia A including factors and other biologics.
Treatment options for von Willebrand Disease (VWD).
